These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 34736365

  • 1. Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture.
    Wang X, Loh B, Gordillo Altamirano F, Yu Y, Hua X, Leptihn S.
    Emerg Microbes Infect; 2021 Dec; 10(1):2205-2219. PubMed ID: 34736365
    [Abstract] [Full Text] [Related]

  • 2. Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials.
    Gordillo Altamirano F, Forsyth JH, Patwa R, Kostoulias X, Trim M, Subedi D, Archer SK, Morris FC, Oliveira C, Kielty L, Korneev D, O'Bryan MK, Lithgow TJ, Peleg AY, Barr JJ.
    Nat Microbiol; 2021 Feb; 6(2):157-161. PubMed ID: 33432151
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhanced antibacterial effect of a novel Friunavirus phage vWU2001 in combination with colistin against carbapenem-resistant Acinetobacter baumannii.
    Wintachai P, Phaonakrop N, Roytrakul S, Naknaen A, Pomwised R, Voravuthikunchai SP, Surachat K, Smith DR.
    Sci Rep; 2022 Feb 16; 12(1):2633. PubMed ID: 35173237
    [Abstract] [Full Text] [Related]

  • 5. New Mutations Involved in Colistin Resistance in Acinetobacter baumannii.
    Sun B, Liu H, Jiang Y, Shao L, Yang S, Chen D.
    mSphere; 2020 Apr 01; 5(2):. PubMed ID: 32238571
    [Abstract] [Full Text] [Related]

  • 6. Antibiotics Act with vB_AbaP_AGC01 Phage against Acinetobacter baumannii in Human Heat-Inactivated Plasma Blood and Galleria mellonella Models.
    Grygorcewicz B, Roszak M, Golec P, Śleboda-Taront D, Łubowska N, Górska M, Jursa-Kulesza J, Rakoczy R, Wojciuk B, Dołęgowska B.
    Int J Mol Sci; 2020 Jun 19; 21(12):. PubMed ID: 32575645
    [Abstract] [Full Text] [Related]

  • 7. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V, Gartenmann S, Tötzl M, Lucchini V, Schellhorn B, Pieren M, Lociuro S, Gitzinger M, Tigges M, Bumann D, Kemmer C.
    mBio; 2019 Jul 16; 10(4):. PubMed ID: 31311879
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of a phage cocktail in controlling phage resistance development in multidrug resistant Acinetobacter baumannii.
    Yuan Y, Wang L, Li X, Tan D, Cong C, Xu Y.
    Virus Res; 2019 Oct 15; 272():197734. PubMed ID: 31465789
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. pmrCAB Recombination Events among Colistin-Susceptible and -Resistant Acinetobacter baumannii Clinical Isolates Belonging to International Clone 7.
    Nodari CS, Fuchs SA, Xanthopoulou K, Cayô R, Seifert H, Gales AC, Dilthey A, Higgins PG.
    mSphere; 2021 Dec 22; 6(6):e0074621. PubMed ID: 34851165
    [Abstract] [Full Text] [Related]

  • 14. Investigation of Novel pmrB and eptA Mutations in Isogenic Acinetobacter baumannii Isolates Associated with Colistin Resistance and Increased Virulence In Vivo.
    Gerson S, Betts JW, Lucaßen K, Nodari CS, Wille J, Josten M, Göttig S, Nowak J, Stefanik D, Roca I, Vila J, Cisneros JM, La Ragione RM, Seifert H, Higgins PG.
    Antimicrob Agents Chemother; 2019 Mar 22; 63(3):. PubMed ID: 30617096
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic evaluation of the Acinetobacter baumannii phage Phab24 for clinical use.
    Zhang L, Wang X, Hua X, Yu Y, Leptihn S, Loh B.
    Virus Res; 2022 Oct 15; 320():198889. PubMed ID: 35970267
    [Abstract] [Full Text] [Related]

  • 16. Phage-mediated colistin resistance in Acinetobacter baumannii.
    Lucidi M, Imperi F, Artuso I, Capecchi G, Spagnoli C, Visaggio D, Rampioni G, Leoni L, Visca P.
    Drug Resist Updat; 2024 Mar 15; 73():101061. PubMed ID: 38301486
    [Abstract] [Full Text] [Related]

  • 17. Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Vijayakumar S, Swetha RG, Bakthavatchalam YD, Vasudevan K, Abirami Shankar B, Kirubananthan A, Walia K, Ramaiah S, Biswas I, Veeraraghavan B, Anbarasu A.
    Microbiol Spectr; 2024 Feb 06; 12(2):e0251123. PubMed ID: 38214512
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.
    Jeon J, Park JH, Yong D.
    BMC Microbiol; 2019 Apr 02; 19(1):70. PubMed ID: 30940074
    [Abstract] [Full Text] [Related]

  • 19. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
    Carretero-Ledesma M, García-Quintanilla M, Martín-Peña R, Pulido MR, Pachón J, McConnell MJ.
    Virulence; 2018 Dec 31; 9(1):930-942. PubMed ID: 29638177
    [Abstract] [Full Text] [Related]

  • 20. Ability of bacteriophage in resolving wound infection caused by multidrug-resistant Acinetobacter baumannii in uncontrolled diabetic rats.
    Shivaswamy VC, Kalasuramath SB, Sadanand CK, Basavaraju AK, Ginnavaram V, Bille S, Ukken SS, Pushparaj UN.
    Microb Drug Resist; 2015 Apr 31; 21(2):171-7. PubMed ID: 25411824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.